Prevalence of Cardiovascular Disease

Author(s):

Key Takeaways

Cardiovascular disease is a major health concern in the U.S., with high prevalence and significant morbidity and mortality rates.
Lifestyle changes, obesity, diabetes, and hypertension are key contributors to the increasing incidence of cardiovascular disease.
Dyslipidemia management is vital in preventing and managing ASCVD by controlling lipid levels and reducing plaque formation risk.
Effective strategies, including lifestyle modifications and pharmacotherapy, are essential for mitigating cardiovascular disease impact and improving outcomes.

Panelists discuss how cardiovascular disease remains a leading health concern in the United States, examining its rising prevalence, risk factors such as dyslipidemia, and management strategies aligned with AHA guidelines to reduce patient mortality.

Now Viewing

EP: 1.Prevalence of Cardiovascular Disease

EP: 2.AHA Guidelines and Patient Mortality

EP: 3.Role of LDL-C in ASCVD

EP: 4.Pediatric Lipid Screening

EP: 5.Lp(a) in Pediatrics

EP: 6.DCRM Recommendations for Lipid Testing and LDL-C Management

EP: 7.Other Lipid Biomarkers

EP: 8.LDL-C Management in Subpopulations

EP: 9.Cost Considerations for LDL Reduction Therapies

EP: 10.Familial Hypercholesterolemia Testing

EP: 11.Role of Lp(a) in ASCVD Risk

EP: 12.Data Analysis: State of LDL-C Control in Patients With ASCVD

EP: 13.Pediatric Lipid Treatment Recommendations

EP: 14.International Lipid Expert Panel Recommendations and RACING Trial

EP: 15.SPORT Trial

EP: 16.Novel Nonstatin LLTs for Lowering LDL-C and CVD Risk

EP: 17.CLEAR-Outcomes Data: Primary Prevention With Bempedoic Acid

EP: 18.Barriers Associated With Controlling LDL-C

EP: 19.Final Insights

Video content above is prompted by the following:

Can you review the current prevalence and effects of cardiovascular disease in the United States?
- In your opinion, what is contributing to the “rising tide” of this disease?
Please discuss the importance of dyslipidemia management in preventing and managing atherosclerotic cardiovascular disease (ASCVD).